Literature DB >> 24442766

Response: galactose treatment in focal and segmental glomerulosclerosis.

Asha Moudgil1, Kristen Sgambat.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24442766     DOI: 10.1007/s00467-013-2732-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Clinical trial of focal segmental glomerulosclerosis in children and young adults.

Authors:  Debbie S Gipson; Howard Trachtman; Frederick J Kaskel; Tom H Greene; Milena K Radeva; Jennifer J Gassman; Marva M Moxey-Mims; Ronald J Hogg; Sandra L Watkins; Richard N Fine; Susan L Hogan; John P Middleton; V Matti Vehaskari; Patti A Flynn; Leslie M Powell; Suzanne M Vento; June L McMahan; Norman Siegel; Vivette D D'Agati; Aaron L Friedman
Journal:  Kidney Int       Date:  2011-07-06       Impact factor: 10.612

2.  Galactose treatment in focal and segmental glomerulosclerosis.

Authors:  Om P Mishra; Arun K Singh
Journal:  Pediatr Nephrol       Date:  2014-01-18       Impact factor: 3.714

3.  Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome.

Authors:  Kristen Sgambat; Mindy Banks; Asha Moudgil
Journal:  Pediatr Nephrol       Date:  2013-06-22       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.